Literature DB >> 15937688

Edmonton symptom assessment scale: Italian validation in two palliative care settings.

Cecilia Moro1, Cinzia Brunelli, Guido Miccinesi, Mauro Fallai, Piero Morino, Massimo Piazza, Roberto Labianca, Carla Ripamonti.   

Abstract

In the palliative care setting, the Edmonton Symptom Assessment Scale (ESAS) was developed for use in daily symptom assessment of palliative care patients. ESAS considers the presence and severity of nine symptoms common in cancer patients: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, well-being and shortness of breath plus an optional tenth symptom, which can be added by the patient. The aim of this study was to validate the Italian version of ESAS and to evaluate an easy quality of life monitoring system that uses a patient's self-rating symptom assessment in two different palliative care settings: in-patients and home patients. Eighty-three in-patients and 158 home care patients were enrolled. In the latter group, the Italian validated version of the Symptom Distress Scale (SDS) was also administered at the admission of the patients. The two groups of patients have similar median survival, demographic and clinical characteristics, symptom prevalence and overall distress score at baseline. ESAS shows a good concurrent validity with respect to SDS. The correlation between the physical items of ESAS and SDS was shown to be higher than the correlation between the psychological items. The association of ESAS scores and performance status (PS) showed a trend: the higher the symptom score was, the worse was the PS level. Test-retest evaluation, applied in the in-patient group, showed good agreement for depression, well-being and overall distress and a moderate agreement for all the other items. In conclusion, ESAS can be considered a valid, reliable and feasible instrument for physical symptom assessment in routine "palliative care" clinical practice with a potentially different responsiveness in different situations or care settings.

Entities:  

Mesh:

Year:  2005        PMID: 15937688     DOI: 10.1007/s00520-005-0834-3

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  36 in total

1.  A comparison of patient and proxy symptom assessments in advanced cancer patients.

Authors:  C L Nekolaichuk; E Bruera; K Spachynski; T MacEachern; J Hanson; T O Maguire
Journal:  Palliat Med       Date:  1999-07       Impact factor: 4.762

2.  Quality of life in terminal illness: defining and measuring subjective well-being in the dying.

Authors:  S R Cohen; B M Mount
Journal:  J Palliat Care       Date:  1992       Impact factor: 2.250

3.  The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK.

Authors:  E Rees; J Hardy; J Ling; K Broadley; R A'Hern
Journal:  Palliat Med       Date:  1998-03       Impact factor: 4.762

4.  A modular approach to quality-of-life assessment in cancer clinical trials.

Authors:  N K Aaronson; M Bullinger; S Ahmedzai
Journal:  Recent Results Cancer Res       Date:  1988

5.  Palliative care: views of patients and their families.

Authors:  I Higginson; A Wade; M McCarthy
Journal:  BMJ       Date:  1990-08-04

6.  Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation.

Authors:  H Schipper; J Clinch; A McMurray; M Levitt
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

7.  Quality of life as an outcome variable in the management of cancer pain.

Authors:  B R Ferrell; C Wisdom; C Wenzl
Journal:  Cancer       Date:  1989-06-01       Impact factor: 6.860

Review 8.  Quality of life assessment in palliative care.

Authors:  I G Finlay; R Dunlop
Journal:  Ann Oncol       Date:  1994-01       Impact factor: 32.976

9.  A method for assessing the quality of life of cancer patients: replication of the factor structure.

Authors:  J M Bliss; P J Selby; B Robertson; T J Powles
Journal:  Br J Cancer       Date:  1992-06       Impact factor: 7.640

10.  Reconsidering the psychometrics of quality of life assessment in light of response shift and appraisal.

Authors:  Carolyn E Schwartz; Bruce D Rapkin
Journal:  Health Qual Life Outcomes       Date:  2004-03-23       Impact factor: 3.186

View more
  59 in total

1.  Cancer pain management in an oncological ward in a comprehensive cancer center with an established palliative care unit.

Authors:  Sebastiano Mercadante; Costanza Guccione; Simona Di Fatta; Valentina Alaimo; Giovanna Prestia; Rosanna Bellingardo; Vittorio Gebbia; Antonino Giarratano; Alessandra Casuccio
Journal:  Support Care Cancer       Date:  2013-07-26       Impact factor: 3.603

Review 2.  The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments.

Authors:  David Hui; Eduardo Bruera
Journal:  J Pain Symptom Manage       Date:  2016-12-29       Impact factor: 3.612

3.  Discharge outcomes and survival of patients with advanced cancer admitted to an acute palliative care unit at a comprehensive cancer center.

Authors:  David Hui; Ahmed Elsayem; Shana Palla; Maxine De La Cruz; Zhijun Li; Sriram Yennurajalingam; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

4.  PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial.

Authors:  A Necchi; P Giannatempo; L Mariani; E Farè; D Raggi; M Pennati; N Zaffaroni; F Crippa; A Marchianò; N Nicolai; M Maffezzini; E Togliardi; M G Daidone; A M Gianni; R Salvioni; F De Braud
Journal:  Invest New Drugs       Date:  2014-02-26       Impact factor: 3.850

5.  Patient-reported outcomes regarding radiation therapy in patients with multiple myeloma.

Authors:  Ronica Nanda; David Boulware; Rachid Baz; Diane Portman; H Michael Yu; Heather Jim; Peter A S Johnstone
Journal:  Acta Oncol       Date:  2020-06-04       Impact factor: 4.089

6.  The Edmonton symptom assessment system--what do patients think?

Authors:  Sharon Watanabe; Cheryl Nekolaichuk; Crystal Beaumont; Asifa Mawani
Journal:  Support Care Cancer       Date:  2008-10-25       Impact factor: 3.603

7.  Predictors of response to palliative care intervention for chronic nausea in advanced cancer outpatients.

Authors:  Wadih Rhondali; Sriram Yennurajalingam; Gary Chisholm; Jeanette Ferrer; Sun Hyun Kim; Jung Hun Kang; Marilene Filbet; Eduardo Bruera
Journal:  Support Care Cancer       Date:  2013-04-16       Impact factor: 3.603

8.  The influence of tumor necrosis factor-alpha -308 G/A and IL-6 -174 G/C on pain and analgesia response in lung cancer patients receiving supportive care.

Authors:  Cielito C Reyes-Gibby; Badi El Osta; Margaret R Spitz; Henrique Parsons; Razelle Kurzrock; Xifeng Wu; Sanjay Shete; Eduardo Bruera
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer.

Authors:  Muhammad Wasif Saif; Jia Li; Lynne Lamb; Kristin Kaley; Kyle Elligers; Zaoli Jiang; Scott Bussom; Shwu-Huey Liu; Yung-Chi Cheng
Journal:  Cancer Chemother Pharmacol       Date:  2013-12-03       Impact factor: 3.333

10.  The Effect of Message Content and Clinical Outcome on Patients' Perception of Physician Compassion: A Randomized Controlled Trial.

Authors:  Kimberson Tanco; Ahsan Azhar; Wadih Rhondali; Alfredo Rodriguez-Nunez; Diane Liu; Jimin Wu; Walter Baile; Eduardo Bruera
Journal:  Oncologist       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.